Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease

Circulation Journal

Volumn 76, Issue 1, 2012, Pages 168-175

  Nakajima, Kenichi ^a   Matsuo, Shinro ^a   Okuyama, Chio ^b   Hatta, Tsuguru ^c   Tsukamoto, Kazumasa ^d   Nishimura, Shigeyuki ^f   Yamashina, Akira ^e   Kusuoka, Hideo ^a   Nishimura, Tsunehiko ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Ohmihachiman Community Medical Center   (Japan)

^d TOHO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^f OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Cardiac event; Chronic kidney disease; Diabetes mellitus; Myocardial perfusion imaging; Risk stratification

Indexed keywords

AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC DISEASE; DATABASES, FACTUAL; DEATH, SUDDEN, CARDIAC; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; JAPAN; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 84255189660     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0857     Document Type: Article

References (34)

1. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
2. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003; 108: 1404-1418.
3. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-1291.
4. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: JACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-328.
5. Matsumoto N, Sato Y, Suzuki Y, Kunimasa T, Yoda S, Iida J, et al. Prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in a Japanese population: A middle-term follow-up study. Circ J 2007; 71: 1580-1585.
6. Nagao T, Chikamori T, Hida S, Igarashi Y, Kuwabara Y, Nishimura S, et al. Quantitative gated single-photon emission computed tomography with 99mTc sestamibi predicts major cardiac events in elderly patients with known or suspected coronary artery disease: The QGSPrognostic Value in the Elderly (Q-PROVE) Study. Circ J 2007; 71: 1029-1034.
7. Hashimoto A, Nakata T, Wakabayashi T, Kusuoka H, Nishimura T. Incremental prognostic value of stress/rest gated perfusion SPECT in patients with coronary artery disease: Subanalysis of the JACCESS study. Circ J 2009; 73: 2288-2293.
8. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, et al. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol 2010; 105: 1698-1704.
9. Kita T. Coronary heart disease risk in Japan: An East/West divide? Eur Heart J 2004; 6(Suppl A): A8-A11.
10. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Prognostic value of myocardial perfusion and ventricular function in a Japanese multicenter cohort study (J-ACCESS): The first-year total events and hard events. Ann Nucl Med 2009; 23: 373-381.
11. Nakajima K, Nishimura T. Prognostic table for predicting major cardiac events based on J-ACCESS investigation. Ann Nucl Med 2008; 22: 891-897.
12. Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009; 36: 1835-1841.
13. Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008; 118: 2540-2549.
14. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
15. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004; 11: 414-423.
16. Nakajima K, Matsuo S, Okuda K, Wakabayashi H, Tsukamoto K, Nishimura T. Estimation of cardiac event risk by gated myocardial perfusion imaging and quantitative scoring methods based on a multicenter J-ACCESS database. Circ J 2011; 75: 2417-2423.
17. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: A study based on the J-ACCESS database. Eur J Nucl Med Mol Imaging 2007; 34: 1088-1096.
18. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28.
19. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
20. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama study. Stroke 2003; 34: 2349-2354.
21. NIPPON DATA80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006; 70: 1249-1255.
22. Tamaki N. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J 2005; 69(Suppl IV): 1125-1202.
23. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008; 117: 261-295.
24. Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S, et al. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium- 99 m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol 2006; 97: 1538-1544.
25. Matsumoto N, Nagao K, Hirayama A, Sato Y. Non-invasive assessment and clinical strategy of stable coronary artery disease by magnetic resonance imaging, multislice computed tomography and myocardial perfusion SPECT. Circ J 2010; 74: 34-40.
26. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107: 2900-2907.
27. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
28. Cano JF, Baena-Diez JM, Franch J, Vila J, Tello S, Sala J, et al. Longterm cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: A population-based cohort study in southern Europe. Diabetes Care 2010; 33: 2004-2009.
29. Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, et al. Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes: The JACCESS 2 investigation. Diabetes Care 2010; 33: 2320-2326.
30. Nakajima K, Yamasaki Y, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, et al. Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: A 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2009; 36: 2049-2057.
31. Okuyama C, Nakajima K, Hatta T, Nishimura S, Kusuoka H, Yamashina A, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for patients with diabetes and chronic kidney disease. Nucl Med Commun 2011; 32: 913-919.
32. Iseki K. Chronic kidney disease in Japan. Intern Med 2008; 47: 681-689.
33. Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, et al. Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens Res 2008; 31: 433-441.
34. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005; 45: 722-729.